CD40LG and metastatic melanoma: In metastatic melanoma, IgG and IgM antiganglioside antibodies had the following profile (%): anti-GM1 (1.2 and 2.9), anti-GM2 (0 and 2.3), anti-GM3 (0 and 0.2), anti-GD1a (0 and 1.7), anti-GD1b (0 and 2.9), anti-GT1b (0 and 0.6), and anti-GQ1b (0 and 0.6).